国药一致(000028) - 2025 Q2 - 季度业绩

Sinopharm Accord Medicine Co., Ltd. 2025 H1 Preliminary Earnings Report Key Financial Data and Indicators The company's core financial indicators showed a downward trend in H1 2025, while total assets expanded Key Financial Data for H1 2025 | Key Financial Indicator | Current Period | Prior Year Period | YoY Change (%) | | :--- | :--- | :--- | :--- | | Total Operating Revenue | CNY 36.80 billion | CNY 37.79 billion | -2.62% | | Operating Profit | CNY 926.50 million | CNY 948.86 million | -2.36% | | Total Profit | CNY 918.11 million | CNY 957.97 million | -4.16% | | Net Profit Attributable to Shareholders | CNY 665.91 million | CNY 743.49 million | -10.43% | | Net Profit after Non-recurring Items | CNY 642.86 million | CNY 711.38 million | -9.63% | | Basic Earnings Per Share (CNY) | 1.20 | 1.34 | -10.45% | | Weighted Average ROE | 3.70% | 4.19% | Down 0.49 p.p. | | Total Assets | CNY 50.43 billion | CNY 47.56 billion | 6.04% | | Equity Attributable to Shareholders | CNY 18.14 billion | CNY 17.67 billion | 2.64% | Explanation of Operating Performance and Financial Condition Overall performance was under pressure due to setbacks in the distribution business, partially offset by significant profit growth in the retail segment Segment Performance Analysis The performance of the two core business segments diverged, with the distribution segment declining while the retail segment achieved significant profit growth Segment Performance for H1 2025 | Segment | Operating Revenue (CNY billion) | YoY Change | Net Profit (CNY million) | YoY Change | | :--- | :--- | :--- | :--- | :--- | | Distribution | 26.78 | -1.09% | 482 | -7.82% | | Retail | 10.48 | -6.46% | 17 | +215.81% | - The distribution segment's performance declined due to industry policy changes, intensified market competition, and increased provisions for bad debts from delayed customer payments[5] - The retail segment's profit surged due to an optimized procurement system, strategic store closures, and improved single-store operational quality, which reduced labor and rental costs[5] Other Influencing Factors and Future Outlook A decline in investment income from key associate companies negatively impacted overall profit, prompting a future focus on efficiency and digital transformation - Performance decline in key associate companies, affected by industry policies and market dynamics, led to a reduction in the company's recognized investment income[6] - Future strategy will focus on revenue generation, cost reduction, and efficiency improvement by accelerating digital transformation and deepening refined management[6] Documents for Inspection Reference documents include the comparative balance sheet and income statement, signed and sealed by the company's key management personnel - The documents available for inspection are the comparative balance sheet and income statement, signed and sealed by management[8]